Examining the limits of the buprenorphine interdosing interval: daily, every‐third‐day and every‐fifth‐day dosing regimens
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims. Opioid‐dependent outpatients may be more likely to present for pharmacological treatment if less than daily dosing can be arranged. These studies compared opioid withdrawal symptoms during 24‐, 72‐, and 120‐hour buprenorphine dosing regimens and evaluated participants' preferences for these different dosing regimens. Participants. Thirty‐three opioid‐dependent participants received daily sublingual maintenance doses of 4 mg/70 kg ( n = 14) or 8 mg/70 kg ( n = 19) of liquid buprenorphine. Methods. In Study I participants received, in a random order, three dosing regimens for five repetitions of each: daily maintenance doses every 24 hours (4 or 8 mg/70 kg), triple the daily maintenance dose every 72 hours (12 or 24 mg/70 kg) and quintuple the daily maintenance dose every 120 hours (20 or 40 mg/70 kg). Doses were administered under double‐blind procedures, and placebos were administered on the interposed days during the latter two regimens. Subjective and observer ratings of opioid withdrawal symptoms were assessed daily prior to receipt of each dose. In Study II, a new group of participants received each of the three dosing regimens under open‐dosing procedures and then chose between the different dosing regimens. Findings. Opioid withdrawal symptoms increased significantly during the every‐fifth‐day dosing regimen in both the blind‐ and open‐dosing studies. In the choice phase of Study II, only one participant (7%) chose quintuple‐every‐fifth‐day dosing over all other dosing options. Conclusions. These results suggest that the maximum duration of action of buprenorphine is less than 5 days when five times the daily maintenance dose is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 1×
“BUP is comparable to methadone in retaining opioid-dependent patients in maintenance and detoxi cation trials (Bickel et al., 1988a; Johnson, Jaffe & Fudala, 1992; Ling, 1996, but see Kosten et al., 1993).”
MethodAcute administration of buprenorphine in humans: partial agonist and blockade effects.
Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10510-7 · Cited by 283
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
O’Connor, P., Oliveto, A., Shi, J., Triffleman, E., Carroll, K., Kosten, T., Rounsaville, B., Pakes, J., & Schottenfeld, R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00194-6 · Cited by 174
Cited by
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 585
Buprenorphine: Clinical Pharmacokinetics in the Treatment of Opioid Dependence
Elkader, A., & Sproule, B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544070-00001 · Cited by 335
Giordano, L., Bickel, W., Loewenstein, G., Jacobs, E., Marsch, L., & Badger, G. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1159-2 · Cited by 294
“Administering up to four maintenance doses (a quadruple dose) of buprenorphine at once prevents withdrawal for up to 96 h (Petry et al. 2000).”
BackgroundSelf-citationTreatment of opioid-dependent pregnant women: Clinical and research issues
Jones, H. E., Martin, P. R., Heil, S. H., Kaltenbach, K., Selby, P., Coyle, M. G., Stine, S. M., O'Grady, K. E., Arria, A. M., & Fischer, G. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.10.007 · Cited by 191
“…there has been considerable research investigating the parameters of buprenorphine dosing in non-pregnant patients (e.g., Amass et al., 2001, 2000,1998,1994; Bickel et al., 1999; Greenwald et al., 2002; Petry et al., 2000, 2001), similar research has not yet been conducted in pregnant patients.”
BackgroundGreenwald, M., Johanson, C.-E., Bueller, J., Chang, Y., Moody, D. E., Kilbourn, M., Koeppe, R., & Zubieta, J.-K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.043 · Cited by 124
Metadata
- Authors
- Petry, N. M., Bickel, W. K., & Badger, G. J.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2001-06
- Volume
- 96
- Issue
- 6
- Pages
- 823-834
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2149698378
- Cited by
- 41
- References
- 5
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Examining the limits of the buprenorphine interdosing interval: daily, every‐third‐day and every‐fifth‐day dosing regimens. https://app.cochat.ai/papers/10.1046/j.1360-0443.2001.9668234.x
- The paper
- Petry, N. M., Bickel, W. K., & Badger, G. J. (2001). Examining the limits of the buprenorphine interdosing interval: daily, every‐third‐day and every‐fifth‐day dosing regimens. Addiction. https://doi.org/10.1046/j.1360-0443.2001.9668234.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.